BIOVENTUS INC - A (BVS)
US09075A1088 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 26.80M | 31.80M | 43.90M | 86.80M | 64.50M | |||
| Receivables | 112.90M | 136.90M | 125.00M | 88.40M | 85.40M | |||
| Inventories | 97.60M | 85.40M | 61.70M | 29.10M | 27.30M | |||
| Other Current Assets | 12.20M | 18.40M | 32.50M | 7.50M | 5.80M | |||
| Total Current Assets | 249.50M | 272.60M | 263.10M | 211.80M | 183.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 54.00M | 45.00M | 40.20M | 21.80M | 19.80M | |||
| Investments And Advances | 6.90M | 2.60M | 29.30M | 19.40M | 3.30M | |||
| Goodwill | 7.50M | 13.80M | 147.60M | 49.80M | 49.80M | |||
| Intangibles | 493.30M | 1.04B | 695.20M | 191.70M | 216.50M | |||
| Other Non-Current Assets | N/A | 0.00 | 50.50M | N/A | N/A | |||
| Total Non-Current Assets | 561.60M | 1.10B | 962.80M | 282.70M | 289.40M | |||
| TOTAL ASSETS | 811.10M | 1.37B | 1.23B | 494.50M | 472.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 19.60M | 33.10M | 18.00M | 15.00M | 10.00M | |||
| Accrued Expenses | 118.20M | 113.10M | 137.70M | 98.80M | 67.60M | |||
| Accounts Payable | 17.60M | 37.50M | 16.90M | 4.40M | 6.40M | |||
| Other Current Liabilities | 5.40M | 120.30M | 8.20M | 4.40M | 4.90M | |||
| Total Current Liabilities | 160.80M | 304.00M | 180.90M | 122.60M | 89.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 375.00M | 385.00M | 339.60M | 173.40M | 188.00M | |||
| Deferred Taxes/Income | 0.00 | 154.00M | 133.50M | 3.40M | 3.90M | |||
| Other Non-Current Liabilities | 48.80M | 189.30M | 38.10M | 51.00M | 45.90M | |||
| Total Non-Current Liabilities | 472.80M | 752.10M | 586.00M | 229.60M | 240.40M | |||
| TOTAL LIABILITIES | 633.60M | 1.06B | 766.90M | 352.20M | 329.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -315.40M | -165.30M | -6.60M | -140.70M | -137.90M | |||
| Additional Paid In Capital | 492.50M | 481.90M | 465.30M | N/A | N/A | |||
| Minority Interest | 50.40M | 78.50M | 84.70M | 3.60M | 3.20M | |||
| Common Shares | 100.00K | 100.00K | 100.00K | 281.40M | 281.40M | |||
| Other Shareholders' Equity | 400.00K | -100.00K | 200.00K | 1.60M | -500.00K | |||
| Shares Outstanding | 78.80M | 77.80M | 75.30M | 55.60M | 55.60M | |||
| Tangible Book Value per Share | -4.10 | -9.46 | -5.10 | -4.81 | -5.24 | |||
| Total Shareholders' Equity | 177.50M | 316.60M | 458.90M | 142.20M | 143.00M | |||
| TOTAL LIABILITIES AND EQUITY | 811.10M | 1.37B | 1.23B | 494.50M | 472.40M | |||
| Statistics | ||||||||
| Debt/Equity | 2.11 | 1.22 | 0.74 | 1.22 | 1.31 | |||
| Current Ratio | 1.55 | 0.90 | 1.45 | 1.73 | 2.06 | |||
| Return On Assets (ROA) | -22.45% | -11.56% | 1.58% | 0.89% | -0.15% | |||
| Return On Equity (ROE) | -102.59% | -50.13% | 4.23% | 3.09% | -0.49% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 1.53% | 5.82% | 6.59% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 1.59% | 7.59% | 7.93% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | 10.08% | 49.65% | 48.06% | |||
All data in USD